You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 22, December 11, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (17)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetics, Other
 •Statistics and Research Methods
 •Transplantation
 •Conflict of Interest
 •Medical Ethics
 •Transplantation, Other
 •Alert me on articles by topic

Human Tissue Research in the Genomic Era of Medicine

Balancing Individual and Societal Interests

Ted T. Ashburn, MD, PhD; Sharon K. Wilson, JD; Barry I. Eisenstein, MD

Arch Intern Med. 2000;160:3377-3384.

Advances in DNA sequencing technology and in our understanding of the human genome are ushering in a new era of genomic medicine, one with dramatic potential to not only benefit society through research involving human tissue, but also to cause economic or psychosocial harms to tissue donors and their families. This delicate situation requires that the needs of tissue donors be carefully considered and balanced with those of the medical research community, especially on issues concerning confidentiality, consent, and compensation. We analyzed the tensions between tissue donors and researchers over the research use of human tissue. We also reviewed several approaches, including the establishment of tissue-trustee infrastructures at academic medical centers, aimed at achieving a more equitable balance between individual donor protection and societal benefits derived from tissue-based research.


From Pfizer Inc, Groton, Conn (Dr Ashburn); Office of Science and Technology, Beth Israel Deaconess Medical Center, Boston, Mass (Drs Wilson and Eisenstein); and Harvard Medical School, Boston (Drs Ashburn and Eisenstein). Dr Ashburn is currently employed full time by Pfizer Inc.


RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(22):3508.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
Andanda
J. Med. Ethics 2008;34:171-179.
ABSTRACT | FULL TEXT  

Ethical and legal issues in research involving human subjects: do you want a piece of me?
Kapp
J. Clin. Pathol. 2006;59:335-339.
ABSTRACT | FULL TEXT  

The Ethics of Research Using Biobanks: Reason to Question the Importance Attributed to Informed Consent
Hoeyer et al.
Arch Intern Med 2005;165:97-100.
ABSTRACT | FULL TEXT  

The Charitable Trust as a Model for Genomic Biobanks
Winickoff and Winickoff
NEJM 2003;349:1180-1184.
FULL TEXT  

The Case for Compensation of Tissue Donors
Tavar et al.
Arch Intern Med 2001;161:1924-1925.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.